ProMetic announces scale-up of prion removal resin in plasma product for biopharmace...(red by applicable securities laws andreg...)
Home
Biology
Medicine
Technology
Products
News
Definition
Dictionary
Movies
Links
Tags
Search
RSS
Navigation Links
Biology News
Medicine News
Biology Products
Medicine Products
Biology Definition
Medicine Definition
Biology Technology
Medicine Technology
Biology Dictionary
Medicine Dictionary
HOME
>>
BIOLOGY
>>
TECHNOLOGY
ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
red by applicable securities laws andregulations.
http://www.bio-medicine.org/inc/biomed/biology-technology.asp
http://feeds.bio-medicine.org/latest-biology-technology
Date:1/23/2008
red by applicable securities laws and regulations.
'/>"/>
SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008
PR Newswire.
All rights reserved
0
GOOD
Page:
1
2
3
4
5
Related biology technology :
1
.
ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
2
.
Vapotherm(R) Announces Validation of U.S. Patent
3
.
Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
4
.
Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
5
.
Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability
6
.
Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
7
.
Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
8
.
Peptimmune Announces First Close of Series D Private Financing
9
.
Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
10
.
Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
11
.
Vasogen Announces 2007 Year-End Results
Post Your Comments:
*
Name:
*
Comment:
*
Email:
Breaking Biology Technology:
Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2
Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3
Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4
Waters Ships First Units of SYNAPT G2 Mass Spectrometer 2
Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 2
Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 3
Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property 2
[
0
] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea
[
0
] Waters Ships First Units of SYNAPT G2 Mass Spectrometer
[
0
] Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas
[
0
] Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property
Other Biology Technology:
Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 2
Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 3
Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 4
Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 5
Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 6
Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 7
Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 8
Biodel to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on December 11, 2007 2
Biodel to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on December 11, 2007 3
Kiwa Fertilizer Distribution Network (Hebei) Grows to 900 Terminals 2
Kiwa Fertilizer Distribution Network (Hebei) Grows to 900 Terminals 3
Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting
Biodel to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on December 11, 2007
Kiwa Fertilizer Distribution Network (Hebei) Grows to 900 Terminals
Breaking Biology News(10 mins):
BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2
BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3
Supportive materials will help regenerate heart tissue 2
Small addition to cancer drug may make big difference 2
Small addition to cancer drug may make big difference 3
Advances in lung cancer research announced at conference 55064 1
Advances in lung cancer research announced at conference 55064 2
Dartmouth researchers propose new way to reproduce a black hole 13649 1
Dartmouth researchers propose new way to reproduce a black hole 13649 2
Research shows why low vitamin D raises heart disease risks in diabetics 55057 1
Research shows why low vitamin D raises heart disease risks in diabetics 55057 2
[
0
] BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine
[
0
] Supportive materials will help regenerate heart tissue
[
0
] Small addition to cancer drug may make big difference
Other Biology News:
Lactose intolerance linked to ancestral environment 2
Lactose intolerance linked to ancestral environment 3
Genetic variation alters response to common anti-clotting drug 2
Genetic variation alters response to common anti-clotting drug 3
Quick identification needed to save Florida's citrus industry from devastating disease
Lactose intolerance linked to ancestral environment
Genetic variation alters response to common anti-clotting drug
Biology Products:
Agar (BACTERIOLOGICAL GRADE) from GE Healthcare, formerly Amersham Biosciences
Custom siRNA, HPLC purified, annealed from Ambion
Rabbit Anti-mTOR Monoclonal Antibody, Clone ZMD.414 from Invitrogen
Fok
I from Promega
Biology Navigation
AIDS/HIV
Bioinformatics
Biotechnology
Biochemistry
Cancer
Cell Biology
Developmental Biology
Ecology
Environment
Evolution
Food Technology
Gene
Genetics
Genomics
Health/Medicine
Immunology
Microarray
Microbiology
Molecular
Marine Biology
Nanobiotechnology
Neurobiology
Plant Sciences
Stem Cell
Systems Biology
Virus
Women Health
Medical Navigation
Abortion
Aches
ADHD
Addiction
Alcohol
Allergy
Alternative Medicine
Alzheimer's Dementia
Anxiety/Stress
Arthritis
Autism
Bacteria
Blood
Bird Flu/Avian Flu
Bones
Breast Cancer
Cancer
Cardiovascular
Cervical Cancer
Chikungunya
Cholesterol
Clinical Trials
Colorectal Cancer
Conferences
Crohn's
Cystic Fibrosis
Dengue
Dentistry
Depression
Diabetes
Drug
Eating Disorders
Education
Epilepsy
Erectile Dysfunction
Eye Health/Blindness
Fertility
Flu/Cold
GastroIntestinal
Genetics
Gout
Headache/Migraine
Hearing/Deafness
HIV/AIDS
Huntington's Disease
Hypertension
Immune System/Vaccines
Insurance
Infectious Diseases
Irritable-Bowel Syndrome
Internet
Leukemia
Lifestyle
Liver Disease/Hepatitis
Lung Cancer
Lupus
Mad Cow Disease
Medical Devices
Medical Students/Training
Medicare/Medicaid
Medico
Men's health
Mental Health
MRI/Ultrasound
MRSA/Drug Resistance
Multiple Sclerosis
Muscular Dystrophy
Neurology
Nursing
Nutrition/Diet
Obesity/Weight Loss
Pain/Anesthetics
Parkinson's Disease
Pediatrics/Children's Health
Pharma/Biotech Industry
Pharmacy/Pharmacists
Pregnancy
Premature
Prostate
Psychology/Psychiatry
Rehabilitation
Respiratory/Asthma
SARS
Schizophrenia
Seniors/Aging
Sexual Health
Sleep/Sleep Disorders
Smoking
Statins
Stem Cell Research
Stroke
Surgery
Transplants/Organ Donations
Viruses
Water - Air Quality
Women's Health